Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yelin Fu

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Plos One|July 3, 2020
Using social choice theory and acceptability analysis to measure the value of health systemsHai Shen, Yubing Sui, Yelin Fu
Science Progress|January 11, 2021
Robust optimization approach to emergency mobile facility routingJianxun Li, Kin Keung Lai, Yelin Fu, et al.
Molecular Cancer Therapeutics|May 7, 2020
A Qualitative Transcriptional Signature for Predicting Prognosis and Response to Bevacizumab in Metastatic Colorectal CancerJing Yang, Kai Song, Wenbing Guo, et al.
Journal of Cancer|January 18, 2020
An Exon Signature to Estimate the Tumor Mutational Burden of Right-sided Colon Cancer PatientsWenbing Guo, Yelin Fu, Liangliang Jin, et al.
BMC Genomics|October 25, 2019
A qualitative transcriptional signature for predicting microsatellite instability status of right-sided Colon CancerYelin Fu, Lishuang Qi, Wenbing Guo, et al.
Frontiers in Genetics|November 16, 2020
A Qualitative Transcriptional Signature for Predicting CpG Island Methylator Phenotype Status of the Right-Sided Colon CancerTianyi You, Kai Song, Wenbing Guo, et al.
Briefings in Bioinformatics|March 3, 2020
An absolute human stemness index associated with oncogenic dedifferentiationHailong Zheng, Kai Song, Yelin Fu, et al.
Cancer Gene Therapy|December 6, 2019
Correction: A qualitative transcriptional signature for determining the grade of colorectal adenocarcinomaHailong Zheng, Kai Song, Yelin Fu, et al.
Cancer Gene Therapy|October 10, 2019
A qualitative transcriptional signature for determining the grade of colorectal adenocarcinomaHailong Zheng, Kai Song, Yelin Fu, et al.
The FEBS Journal|March 28, 2020
Qualitative Ras pathway signature for cetuximab therapy reveals resistant mechanism in colorectal cancerKai Song, Haibo Lu, Liangliang Jin, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Plos One|July 3, 2020
Using social choice theory and acceptability analysis to measure the value of health systemsHai Shen, Yubing Sui, Yelin Fu
Science Progress|January 11, 2021
Robust optimization approach to emergency mobile facility routingJianxun Li, Kin Keung Lai, Yelin Fu, et al.
Molecular Cancer Therapeutics|May 7, 2020
A Qualitative Transcriptional Signature for Predicting Prognosis and Response to Bevacizumab in Metastatic Colorectal CancerJing Yang, Kai Song, Wenbing Guo, et al.
Journal of Cancer|January 18, 2020
An Exon Signature to Estimate the Tumor Mutational Burden of Right-sided Colon Cancer PatientsWenbing Guo, Yelin Fu, Liangliang Jin, et al.
BMC Genomics|October 25, 2019
A qualitative transcriptional signature for predicting microsatellite instability status of right-sided Colon CancerYelin Fu, Lishuang Qi, Wenbing Guo, et al.
Frontiers in Genetics|November 16, 2020
A Qualitative Transcriptional Signature for Predicting CpG Island Methylator Phenotype Status of the Right-Sided Colon CancerTianyi You, Kai Song, Wenbing Guo, et al.
Briefings in Bioinformatics|March 3, 2020
An absolute human stemness index associated with oncogenic dedifferentiationHailong Zheng, Kai Song, Yelin Fu, et al.
Cancer Gene Therapy|December 6, 2019
Correction: A qualitative transcriptional signature for determining the grade of colorectal adenocarcinomaHailong Zheng, Kai Song, Yelin Fu, et al.
Cancer Gene Therapy|October 10, 2019
A qualitative transcriptional signature for determining the grade of colorectal adenocarcinomaHailong Zheng, Kai Song, Yelin Fu, et al.
The FEBS Journal|March 28, 2020
Qualitative Ras pathway signature for cetuximab therapy reveals resistant mechanism in colorectal cancerKai Song, Haibo Lu, Liangliang Jin, et al.
Pageof 1